A new report released by the WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) examines the global and ...

The FDA has accepted for review Chiesi’s New Drug Application (NDA) for their investigational maintenance treatment for ...

An expert discusses how treatment decisions must balance short-term burden with long-term benefits while avoiding protocol-driven step therapy requirements, as future comparative effectiveness trials ...

New diagnostics, including lab tests and imaging, are revolutionizing medicine and creating exciting opportunities for ...

Panelists discuss how guselkumab demonstrated a very reassuring safety profile with no new safety signals or unexpected ...

An expert discusses how nonstatin therapies serve as essential tools when patients can’t tolerate statins or need additional ...

Biomarkers are pivotal for confirming diagnoses, predicting disease progression, and tailoring therapeutic modalities. Recent ...

In this interview, Steven Buslovich, M.D., CMD, MS, chief medical officer of senior care at PointClickCare, explains the ...

Vielot and her colleagues found that among 3.45 million people evaluated across 12 emulated trials in analysis 1, the one-year vaccine effectiveness of at least one Shingrix dose was 56.1% against any ...

Research reveals that even with over 25 million losing Medicaid during unwinding in 2023, the uninsured rate remains stable as many quickly re-enroll or switch coverage.

In this video interview, Francesca Bridge, MBBS, neurologist at Alfred Health in Melbourne, Australia, and Ph.D. candidate at Monash University, shares why the results of her latest research were ...

I’d had a number of denials before, but they were all sort of spaced out,” she says. “When I got hit by a car, everything ...